HomeCompareVRRMW vs PFE

VRRMW vs PFE: Dividend Comparison 2026

VRRMW yields 26.53% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VRRMW wins by $58.5K in total portfolio value
10 years
VRRMW
VRRMW
● Live price
26.53%
Share price
$7.54
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$108.1K
Annual income
$12,843.31
Full VRRMW calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — VRRMW vs PFE

📍 VRRMW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVRRMWPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VRRMW + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VRRMW pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VRRMW
Annual income on $10K today (after 15% tax)
$2,254.64/yr
After 10yr DRIP, annual income (after tax)
$10,916.81/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $11,403.09/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VRRMW + PFE for your $10,000?

VRRMW: 50%PFE: 50%
100% PFE50/50100% VRRMW
Portfolio after 10yr
$78.8K
Annual income
$19,551.02/yr
Blended yield
24.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

VRRMW
Analyst Ratings
3
Buy
2
Hold
Consensus: Buy
Altman Z
1.3
Piotroski
7/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VRRMW buys
0
PFE buys
0
No recent congressional trades found for VRRMW or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVRRMWPFE
Forward yield26.53%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$108.1K$49.6K
Annual income after 10y$12,843.31$26,258.71
Total dividends collected$70.2K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyHold

Year-by-year: VRRMW vs PFE ($10,000, DRIP)

YearVRRMW PortfolioVRRMW Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$13,353$2,652.52$9,153$693.39+$4.2KVRRMW
2$17,597$3,310.08$8,593$849.25+$9.0KVRRMW
3$22,906$4,076.96$8,336$1,066.78+$14.6KVRRMW
4$29,469$4,959.72$8,437$1,384.80+$21.0KVRRMW
5$37,495$5,963.37$9,013$1,875.40+$28.5KVRRMW
6$47,211$7,091.17$10,306$2,680.72+$36.9KVRRMW
7$58,861$8,344.52$12,820$4,101.38+$46.0KVRRMW
8$72,704$9,722.92$17,673$6,826.70+$55.0KVRRMW
9$89,017$11,223.93$27,543$12,591.86+$61.5KVRRMW
10$108,091$12,843.31$49,560$26,258.71+$58.5KVRRMW

VRRMW vs PFE: Complete Analysis 2026

VRRMWStock

Verra Mobility Corporation provides smart mobility technology solutions and services in the United States, Australia, Canada, and Europe. It operates through three segments: Commercial Services; Government Solutions; and Parking Solutions. The Government Solutions segment offers automated safety solutions, including services and technologies that enable photo enforcement through road safety camera programs, which detects and process traffic violations related to red light, speed, school bus, and city bus lanes. This segment serves municipalities, counties, school districts, and law enforcement agencies. The Commercial Services segment provides automated toll and violations management, and title and registration services to rental car companies, fleet management companies, and other large fleet owners. The Parking Solutions segment provides an integrated suite of parking software and hardware solutions to universities, municipalities, parking operators, healthcare facilities, and transportation hubs. The company was incorporated in 2016 and is headquartered in Mesa, Arizona.

Full VRRMW Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this VRRMW vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VRRMW vs SCHDVRRMW vs JEPIVRRMW vs OVRRMW vs KOVRRMW vs MAINVRRMW vs JNJVRRMW vs MRKVRRMW vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.